
Cracks are appearing in CMS' drive to publish Physicians Sunshine Act data
Now, CMS will publish 66% of received data on Sept. 30
The runup to the Sept. 30 date for releasing national data on payments to physicians under the Physicians Sunshine Act is becoming challenging, but for now CMS is sticking to that date, at least for what it says are two-thirds of the data that can be confirmed prior to publication. The CMS system, also known as the Open Payments system, was opened for individual physicians to review on Aug. 3; when errors appeared, it was temporarily closed, but then reopened on Aug 15. CMS is giving physicians (and teaching hospitals, among other healthcare organizations) 45 days to dispute the data; that review period has been extended to Sept. 8.
Also during August, the American Medical Assn. and 110 other medical associations
Press coverage has focused on payments made by manufacturers to physicians or their affiliated employers; the logic all along has been that these payments (which can range from in-office pizzas to million-dollar clinical trial projects) influence how physicians prescribe drugs and other healthcare products. But there are many other potential landmines in the data collection: relationships between prescribers and group purchasing organizations, and ownerships of healthcare facilities by physicians and their immediate families.
Industry wags are also comparing the ramp-up of the Open Payments system to last year’s healthcare exchange fiasco (both systems are part of the original Obamacare legislation). However, the tech issues appear to be vastly different; CMS’ Aug. 15 statement cited difficulties such as “the wrong state license number or national provider identifier (NPI), for physicians with the same last and first names.” (And it’s worth noting that the NPI system itself is a CMS operation.)
Fasten your seatbelts, it’s going to be a bumpy ride…
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.